Article Text

PDF

Cannabinoids and glaucoma
  1. I Tomida1,
  2. R G Pertwee2,
  3. A Azuara-Blanco1
  1. 1Department of Ophthalmology, Aberdeen Royal Infirmary, University of Aberdeen, UK
  2. 2Department of Biomedical Sciences, Institute of Medical Sciences, University of Aberdeen, UK
  1. Correspondence to: A Azuara-Blanco PhD FRCS(Ed), The Eye Clinic, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK; Aazblancoaol.com

Abstract

Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • BJO at a glance
      BMJ Publishing Group Ltd.BMA House, Tavistock Square, London, WC1H 9JR